Skip to main content
Erschienen in:

01.06.2008 | Weiterbildung • Zertifizierte Fortbildung

Die Therapie von Frauen mit Endometriumkarzinom

verfasst von: PD Dr. G. Hänsgen, D. Grund, A. Schneider, S. Marnitz, Prof. Dr. C. Köhler

Erschienen in: Die Onkologie | Ausgabe 6/2008

Einloggen, um Zugang zu erhalten

Zusammenfassung

Endometriumkarzinome sind die häufigsten gynäkologischen Malignome, wobei rund 80% in frühen Stadien entdeckt werden. Die wichtigsten Prognosefaktoren sind das Tumorstadium, das histologische Grading und die Tiefe der Tumorinfiltration im Myometrium. Die Indikation für eine postoperative adjuvante Strahlentherapie (als vaginale Brachytherapie allein oder in Kombination mit einer perkutanen Bestrahlung) ist abhängig von den Risikofaktoren und der Operation. Die Rolle einer zusätzlichen systemischen Therapie bedarf weiterer Untersuchungen.
Literatur
1.
Zurück zum Zitat Aalders J, Abeler V, Kolstad P, Onsrud M (1980) Postoperative external irradiation and prognostic parameters in stage I endometrial carcinoma: clinical and histopathologic study of 540 patients. Obstet Gynecol 56: 419–427PubMed Aalders J, Abeler V, Kolstad P, Onsrud M (1980) Postoperative external irradiation and prognostic parameters in stage I endometrial carcinoma: clinical and histopathologic study of 540 patients. Obstet Gynecol 56: 419–427PubMed
2.
Zurück zum Zitat Carey MS, O’Connell GJ, Johanson CR et al. (1995) Good outcome associated with a standardized treatment protocol using selective postoperative radiation in patients with clinical stage I adenocarcinoma of the endometrium. Gynecol Oncol 57: 138–144PubMedCrossRef Carey MS, O’Connell GJ, Johanson CR et al. (1995) Good outcome associated with a standardized treatment protocol using selective postoperative radiation in patients with clinical stage I adenocarcinoma of the endometrium. Gynecol Oncol 57: 138–144PubMedCrossRef
3.
Zurück zum Zitat Chan JK, Cheung MK, Huh WK et al. (2006) Therapeutic role of lymph node resection in endometrioid corpus cancer: a study of 12,333 patients. Cancer 107: 1823–1830PubMedCrossRef Chan JK, Cheung MK, Huh WK et al. (2006) Therapeutic role of lymph node resection in endometrioid corpus cancer: a study of 12,333 patients. Cancer 107: 1823–1830PubMedCrossRef
4.
Zurück zum Zitat Chan JK, Lin YG, Monk BJ et al. (2001) Vaginal hysterectomy as primary treatment of endometrial cancer in medically compromised women. Obstet Gynecol 97: 707–711PubMedCrossRef Chan JK, Lin YG, Monk BJ et al. (2001) Vaginal hysterectomy as primary treatment of endometrial cancer in medically compromised women. Obstet Gynecol 97: 707–711PubMedCrossRef
5.
Zurück zum Zitat Chu CS, Randall TC, Bandera CA, Rubin SC (2003) Vaginal cuff recurrence of endometrial cancer treated by laparoscopic-assisted vaginal hysterectomy. Gynecol Oncol 88: 62–65PubMedCrossRef Chu CS, Randall TC, Bandera CA, Rubin SC (2003) Vaginal cuff recurrence of endometrial cancer treated by laparoscopic-assisted vaginal hysterectomy. Gynecol Oncol 88: 62–65PubMedCrossRef
6.
Zurück zum Zitat Cragun JM, Havrilesky LJ, Calingaert B et al. (2005) Retrospective analysis of selective lymphadenectomy in apparent earlystage endometrial cancer. J Clin Oncol 23: 3668–3675PubMedCrossRef Cragun JM, Havrilesky LJ, Calingaert B et al. (2005) Retrospective analysis of selective lymphadenectomy in apparent earlystage endometrial cancer. J Clin Oncol 23: 3668–3675PubMedCrossRef
7.
Zurück zum Zitat Creasman WT, Morrow CP, Bundy BN et al. (1987) Surgical pathologic spread patterns of endometrial cancer. A Gynecologic Oncology Group Study. Cancer (Suppl) 60: 2035–2041 Creasman WT, Morrow CP, Bundy BN et al. (1987) Surgical pathologic spread patterns of endometrial cancer. A Gynecologic Oncology Group Study. Cancer (Suppl) 60: 2035–2041
8.
Zurück zum Zitat Creutzberg CL, Putten WL van, Koper PC et al. (2000) Surgery and postoperative radiotherapy versus surgery alone for patients with stage-1 endometrial carcinoma: multicentre randomised trial. PORTEC Study Group. Post operative radiation therapy in endometrial carcinoma. Lancet 355: 1404–1411PubMedCrossRef Creutzberg CL, Putten WL van, Koper PC et al. (2000) Surgery and postoperative radiotherapy versus surgery alone for patients with stage-1 endometrial carcinoma: multicentre randomised trial. PORTEC Study Group. Post operative radiation therapy in endometrial carcinoma. Lancet 355: 1404–1411PubMedCrossRef
9.
Zurück zum Zitat Fanning J (2001) Long-term survival of intermediate risk endometrial cancer (stage IG3, IC, II) treated with full lymphadenectomy and brachytherapy without teletherapy. Gynecol Oncol 82: 371–374PubMedCrossRef Fanning J (2001) Long-term survival of intermediate risk endometrial cancer (stage IG3, IC, II) treated with full lymphadenectomy and brachytherapy without teletherapy. Gynecol Oncol 82: 371–374PubMedCrossRef
10.
Zurück zum Zitat Fung-Kee-Fung M, Dodge J, Elit L et al. Cancer Care Ontario Program in Evidence-based Care Gynecology Cancer Disease Site Group (2006) Follow-up after primary therapy for endometrial cancer: a systematic review. Gynecol Oncol 101: 520–529PubMedCrossRef Fung-Kee-Fung M, Dodge J, Elit L et al. Cancer Care Ontario Program in Evidence-based Care Gynecology Cancer Disease Site Group (2006) Follow-up after primary therapy for endometrial cancer: a systematic review. Gynecol Oncol 101: 520–529PubMedCrossRef
11.
Zurück zum Zitat Greven K, Winter K, Underhill K et al. (2006) Final analysis of RTOG 9708: adjuvant postoperative irradiation combined with cisplatin/paclitaxel chemotherapy following surgery for patients with high-risk endometrial cancer. Gynecol Oncol 103: 155−159PubMedCrossRef Greven K, Winter K, Underhill K et al. (2006) Final analysis of RTOG 9708: adjuvant postoperative irradiation combined with cisplatin/paclitaxel chemotherapy following surgery for patients with high-risk endometrial cancer. Gynecol Oncol 103: 155−159PubMedCrossRef
12.
Zurück zum Zitat Hänsgen G, Nagel M, Dunst J, Enke H (1999) Postoperative radiotherapy in endometrial carcinoma. A retrospective analysis of 541 cases. Strahlenther Onkol 175: 548–553PubMedCrossRef Hänsgen G, Nagel M, Dunst J, Enke H (1999) Postoperative radiotherapy in endometrial carcinoma. A retrospective analysis of 541 cases. Strahlenther Onkol 175: 548–553PubMedCrossRef
13.
Zurück zum Zitat Hogberg T, Rosenberg P, Kristensen G et al. (2007) A randomized phase-III study on adjuvant treatment with radiation (RT) ± chemotherapy (CT) in early-stage high-risk endometrial cancer (NSGO-EC-9501/EORTC 55991). J Clin Oncol Proceedings (Suppl) 25: 5503 Hogberg T, Rosenberg P, Kristensen G et al. (2007) A randomized phase-III study on adjuvant treatment with radiation (RT) ± chemotherapy (CT) in early-stage high-risk endometrial cancer (NSGO-EC-9501/EORTC 55991). J Clin Oncol Proceedings (Suppl) 25: 5503
14.
Zurück zum Zitat Holland CM, Latimer JA, Crawford RA (2004) Vaginal cuff recurrence of endometrial cancer treated by laparoscopic-assisted vaginal hysterectomy. Gynecol Oncol 92: 1015–1016PubMedCrossRef Holland CM, Latimer JA, Crawford RA (2004) Vaginal cuff recurrence of endometrial cancer treated by laparoscopic-assisted vaginal hysterectomy. Gynecol Oncol 92: 1015–1016PubMedCrossRef
15.
Zurück zum Zitat Holub Z, Jabor A, Bartos P et al. (2002) Laparoscopic surgery for endometrial cancer: long-term results of a multicentric study. Eur J Gynaecol Oncol 23: 305–310PubMed Holub Z, Jabor A, Bartos P et al. (2002) Laparoscopic surgery for endometrial cancer: long-term results of a multicentric study. Eur J Gynaecol Oncol 23: 305–310PubMed
17.
Zurück zum Zitat Kaufmann M, Beckmann MW, Emons G et al. (2006) Aktuelle Empfehlungen der Arbeitsgemeinschaft Gynäkologische Onkologie. Zuckschwerdt, München Wien New York Kaufmann M, Beckmann MW, Emons G et al. (2006) Aktuelle Empfehlungen der Arbeitsgemeinschaft Gynäkologische Onkologie. Zuckschwerdt, München Wien New York
18.
Zurück zum Zitat Kennedy AW, Austin JM, Look KY, Munger CB (2000) The Society of Gynecologic Oncologists Outcomes Task Force. Study of endometrical cancer: initial experiences. Gynecol Oncol 79: 379–398PubMedCrossRef Kennedy AW, Austin JM, Look KY, Munger CB (2000) The Society of Gynecologic Oncologists Outcomes Task Force. Study of endometrical cancer: initial experiences. Gynecol Oncol 79: 379–398PubMedCrossRef
19.
Zurück zum Zitat Keys HM, Roberts JA, Brunetto VL et al. Gynecologic Oncology Group (2004) A phase III trial of surgery with or without adjunctive external pelvic radiation therapy in intermediate risk endometrial adenocarcinoma: a Gynecologic Oncology Group study. Gynecol Oncol 92: 744–751PubMedCrossRef Keys HM, Roberts JA, Brunetto VL et al. Gynecologic Oncology Group (2004) A phase III trial of surgery with or without adjunctive external pelvic radiation therapy in intermediate risk endometrial adenocarcinoma: a Gynecologic Oncology Group study. Gynecol Oncol 92: 744–751PubMedCrossRef
20.
Zurück zum Zitat Kilgore LC, Partridge EE, Alvarez RD et al. (1995) Adenocarcinoma of the endometrium: survival comparisons of patients with and without pelvic node sampling. Gynecol Oncol 56: 29–33PubMedCrossRef Kilgore LC, Partridge EE, Alvarez RD et al. (1995) Adenocarcinoma of the endometrium: survival comparisons of patients with and without pelvic node sampling. Gynecol Oncol 56: 29–33PubMedCrossRef
21.
Zurück zum Zitat Knocke TH, Kucera H, Weidinger B et al. (1997) Primary treatment of endometrial carcinoma with high-dose-rate brachytherapy: results of 12 years of experience with 280 patients. Int J Radiat Oncol Biol Phys 37: 359–365PubMed Knocke TH, Kucera H, Weidinger B et al. (1997) Primary treatment of endometrial carcinoma with high-dose-rate brachytherapy: results of 12 years of experience with 280 patients. Int J Radiat Oncol Biol Phys 37: 359–365PubMed
22.
Zurück zum Zitat Kong A, Johnson N, Cornes P et al. (2007) Adjuvant radiotherapy for stage I endometrial cancer. Cochrane Database Syst Rev: CD003916 Kong A, Johnson N, Cornes P et al. (2007) Adjuvant radiotherapy for stage I endometrial cancer. Cochrane Database Syst Rev: CD003916
23.
Zurück zum Zitat Kucera H, Vavra N, Weghaupt K (1990) Benefit of external irradiation in pathologic stage I endometrial carcinoma: A prospective clinical trial of 605 patients who received postoperative vaginal irradiation and additional pelvic irradiation in the presence of unfavorable prognostic factors. Gynecol Oncol 38: 99–104PubMedCrossRef Kucera H, Vavra N, Weghaupt K (1990) Benefit of external irradiation in pathologic stage I endometrial carcinoma: A prospective clinical trial of 605 patients who received postoperative vaginal irradiation and additional pelvic irradiation in the presence of unfavorable prognostic factors. Gynecol Oncol 38: 99–104PubMedCrossRef
24.
Zurück zum Zitat Lelle RJ, Morley GW, Peters WA (1994) The role of vaginal hysterectomy in the treatment of endometrial carcinoma. Int J Gynecol Cancer 4: 342–347PubMedCrossRef Lelle RJ, Morley GW, Peters WA (1994) The role of vaginal hysterectomy in the treatment of endometrial carcinoma. Int J Gynecol Cancer 4: 342–347PubMedCrossRef
25.
Zurück zum Zitat Lin LL, Mutch DG, Rader JS et al. (2007) External radiotherapy versus vaginal brachytherapy for patients with intermediate risk endometrial cancer. Gynecol Oncol 106: 215–220PubMedCrossRef Lin LL, Mutch DG, Rader JS et al. (2007) External radiotherapy versus vaginal brachytherapy for patients with intermediate risk endometrial cancer. Gynecol Oncol 106: 215–220PubMedCrossRef
26.
Zurück zum Zitat Lukka H, Chambers A, Fyles A et al. (2006) Adjuvant radiotherapy in women with stage I endometrial cancer: a systematic review. Gynecol Oncol 102: 361–368PubMedCrossRef Lukka H, Chambers A, Fyles A et al. (2006) Adjuvant radiotherapy in women with stage I endometrial cancer: a systematic review. Gynecol Oncol 102: 361–368PubMedCrossRef
27.
Zurück zum Zitat Maggi R, Lissoni A, Spina F et al. (2006) Adjuvant chemotherapy vs radiotherapy in high-risk endometrial carcinoma: results of a randomised trial. Br J Cancer 95: 266–271PubMedCrossRef Maggi R, Lissoni A, Spina F et al. (2006) Adjuvant chemotherapy vs radiotherapy in high-risk endometrial carcinoma: results of a randomised trial. Br J Cancer 95: 266–271PubMedCrossRef
28.
Zurück zum Zitat Mariani A, Dowdy SC, Cliby WA et al. (2006) Efficacy of systematic lymphadenectomy and adiuvant radiotherapy in node-positive endometrial cancer patients. Gynecol Oncol 101: 200–208PubMedCrossRef Mariani A, Dowdy SC, Cliby WA et al. (2006) Efficacy of systematic lymphadenectomy and adiuvant radiotherapy in node-positive endometrial cancer patients. Gynecol Oncol 101: 200–208PubMedCrossRef
29.
Zurück zum Zitat Mariani A, Keeny GL, Aletti G et al. (2004) Endometrial carcinoma: paraaortic dissemination. Gynecol Oncol 92: 833–838PubMedCrossRef Mariani A, Keeny GL, Aletti G et al. (2004) Endometrial carcinoma: paraaortic dissemination. Gynecol Oncol 92: 833–838PubMedCrossRef
30.
Zurück zum Zitat Mariani A, Webb MJ, Galli L, Podratz KC (2000) Potential therapeutic role of para-aortic lymphadenectomy in node-positive endometrial cancer. Gynecol Oncol 76: 348–356PubMedCrossRef Mariani A, Webb MJ, Galli L, Podratz KC (2000) Potential therapeutic role of para-aortic lymphadenectomy in node-positive endometrial cancer. Gynecol Oncol 76: 348–356PubMedCrossRef
31.
Zurück zum Zitat Martinez AA, Weiner S, Podratz K et al. (2003) Improved outcome at 10 years for serous-papillary/clear cell or high-risk endometrial cancer patients treated by adjuvant high-dose whole abdomino-pelvic irradiation. Gynecol Oncol 90: 537–546PubMedCrossRef Martinez AA, Weiner S, Podratz K et al. (2003) Improved outcome at 10 years for serous-papillary/clear cell or high-risk endometrial cancer patients treated by adjuvant high-dose whole abdomino-pelvic irradiation. Gynecol Oncol 90: 537–546PubMedCrossRef
32.
Zurück zum Zitat McMeekin DS, Lashbrook D, Gold M et al. (2001) Analysis of FIGO stage IIIc endometrial cancer patients. Gynecol Oncol 81: 273–278PubMedCrossRef McMeekin DS, Lashbrook D, Gold M et al. (2001) Analysis of FIGO stage IIIc endometrial cancer patients. Gynecol Oncol 81: 273–278PubMedCrossRef
33.
Zurück zum Zitat Mohan DS, Samuels MA, Selim MA et al. (1998) Long-term outcomes of therapeutic pelvic lymphadenectomy for stage I endometrial adenocarcinoma. Gynecol Oncol 70: 165–171PubMedCrossRef Mohan DS, Samuels MA, Selim MA et al. (1998) Long-term outcomes of therapeutic pelvic lymphadenectomy for stage I endometrial adenocarcinoma. Gynecol Oncol 70: 165–171PubMedCrossRef
34.
Zurück zum Zitat Morrow CP, Bundy BN, Kurman RJ et al. (1991) Relationship between surgical-pathological risk factors and outcome in clinical stage I and II carcinoma of the endometrium: a Gynecologic Oncology Group study. Gynecol Oncol 40: 55–65PubMedCrossRef Morrow CP, Bundy BN, Kurman RJ et al. (1991) Relationship between surgical-pathological risk factors and outcome in clinical stage I and II carcinoma of the endometrium: a Gynecologic Oncology Group study. Gynecol Oncol 40: 55–65PubMedCrossRef
35.
Zurück zum Zitat Nelson G, Randall M, Sutton G et al. (1999) FIGO stage IIIC endometrial carcinoma with metastases confined to pelvic lymph nodes: analysis of treatment outcomes, prognostic variables, and failure patterns following adjuvant radiation therapy. Gynecol Oncol 75: 211–214PubMedCrossRef Nelson G, Randall M, Sutton G et al. (1999) FIGO stage IIIC endometrial carcinoma with metastases confined to pelvic lymph nodes: analysis of treatment outcomes, prognostic variables, and failure patterns following adjuvant radiation therapy. Gynecol Oncol 75: 211–214PubMedCrossRef
36.
Zurück zum Zitat Nezhat CR, Burrell MO, Nezhat FR et al. (1992) Laparoscopic radical hysterectomy with paraaortic and pelvic node dissection. Am J Obstet Gynecol 166: 864–865PubMed Nezhat CR, Burrell MO, Nezhat FR et al. (1992) Laparoscopic radical hysterectomy with paraaortic and pelvic node dissection. Am J Obstet Gynecol 166: 864–865PubMed
37.
Zurück zum Zitat Niazi TM, Souhami L, Portelance L et al. (2005) Long-term results of high-dose-rate brachytherapy in the primary treatment of medically inoperable stage I–II endometrial carcinoma. Int J Radiat Oncol Biol Phys 63: 1108–1113PubMed Niazi TM, Souhami L, Portelance L et al. (2005) Long-term results of high-dose-rate brachytherapy in the primary treatment of medically inoperable stage I–II endometrial carcinoma. Int J Radiat Oncol Biol Phys 63: 1108–1113PubMed
38.
Zurück zum Zitat Obermair A, Manolitsas TP, Leung Y et al. (2004) Total laparoscopic hysterectomy for endometrial cancer: patterns of recurrence and survival. Gynecol Oncol 99: 789–793CrossRef Obermair A, Manolitsas TP, Leung Y et al. (2004) Total laparoscopic hysterectomy for endometrial cancer: patterns of recurrence and survival. Gynecol Oncol 99: 789–793CrossRef
39.
Zurück zum Zitat Patel S, Portelance L, Gilbert L et al. (in press) Analysis of prognostic factors and patterns of recurrence in patients with pathologic Stage III endometrial cancer. Int J Radiat Oncol Biol Phys 68: 1438–1445 Patel S, Portelance L, Gilbert L et al. (in press) Analysis of prognostic factors and patterns of recurrence in patients with pathologic Stage III endometrial cancer. Int J Radiat Oncol Biol Phys 68: 1438–1445
40.
Zurück zum Zitat Querleu D, Leblanc E, Castelain B (1991) Laparoscopic pelvic lymphadenectomy in the staging of early carcinoma of the cervix. Am J Obstet Gynecol 164: 579–581PubMed Querleu D, Leblanc E, Castelain B (1991) Laparoscopic pelvic lymphadenectomy in the staging of early carcinoma of the cervix. Am J Obstet Gynecol 164: 579–581PubMed
41.
Zurück zum Zitat Ramirez PT, Frumovitz M, Wolf JK, Levenback C (2004) Laparoscopic port-site metastases in patients with gynecological malignancies. Int J Gynecol Cancer 14: 1070–1077PubMedCrossRef Ramirez PT, Frumovitz M, Wolf JK, Levenback C (2004) Laparoscopic port-site metastases in patients with gynecological malignancies. Int J Gynecol Cancer 14: 1070–1077PubMedCrossRef
42.
Zurück zum Zitat Randall ME, Filiaci VL, Muss H et al.; Gynecologic Oncology Group (2006) Randomized phase III trial of whole-abdominal irradiation versus doxorubicin and cisplatin chemotherapy in advanced endometrial carcinoma: a Gynecologic Oncology Group Study. J Clin Oncol 24: 36–44PubMedCrossRef Randall ME, Filiaci VL, Muss H et al.; Gynecologic Oncology Group (2006) Randomized phase III trial of whole-abdominal irradiation versus doxorubicin and cisplatin chemotherapy in advanced endometrial carcinoma: a Gynecologic Oncology Group Study. J Clin Oncol 24: 36–44PubMedCrossRef
43.
Zurück zum Zitat Reich H, De Caprio J, McGlynn F (1989) Laparoscopic hysterectomy. J Gynecol Surg 5: 213–216CrossRef Reich H, De Caprio J, McGlynn F (1989) Laparoscopic hysterectomy. J Gynecol Surg 5: 213–216CrossRef
44.
Zurück zum Zitat Rittenberg PV, Lotocki RJ, Heywood MS et al. (2003) High-risk surgical stage 1 endometrial cancer: outcomes with vault brachytherapy alone. Gynecol Oncol 9: 288–294CrossRef Rittenberg PV, Lotocki RJ, Heywood MS et al. (2003) High-risk surgical stage 1 endometrial cancer: outcomes with vault brachytherapy alone. Gynecol Oncol 9: 288–294CrossRef
45.
Zurück zum Zitat Schneider A (2004) Vaginal cuff recurrence of endometrial cancer treated by laparoscopic-assisted vaginal hysterectomy. Gynecol Oncol 94: 861; author reply 861PubMedCrossRef Schneider A (2004) Vaginal cuff recurrence of endometrial cancer treated by laparoscopic-assisted vaginal hysterectomy. Gynecol Oncol 94: 861; author reply 861PubMedCrossRef
46.
Zurück zum Zitat Scholten AN, Putten WL van, Beerman H et al. PORTEC Study Group (2005) Postoperative radiotherapy for Stage 1 endometrial carcinoma: long-term outcome of the randomized PORTEC trial with central pathology review. Int J Radiat Oncol Biol Phys 63: 834–838PubMed Scholten AN, Putten WL van, Beerman H et al. PORTEC Study Group (2005) Postoperative radiotherapy for Stage 1 endometrial carcinoma: long-term outcome of the randomized PORTEC trial with central pathology review. Int J Radiat Oncol Biol Phys 63: 834–838PubMed
47.
Zurück zum Zitat Scribner DR, Mannel RS, Walker JL, Johnson GA (1999) Cost analysis of laparoscopy versus laparotomy for early endometrial cancer. Gynecol Oncol 75: 460–463PubMedCrossRef Scribner DR, Mannel RS, Walker JL, Johnson GA (1999) Cost analysis of laparoscopy versus laparotomy for early endometrial cancer. Gynecol Oncol 75: 460–463PubMedCrossRef
48.
Zurück zum Zitat Shaeffer DT, Randall ME (2005) Adjuvant radiotherapy in endometrial carcinoma. Oncologist 10: 623–631PubMedCrossRef Shaeffer DT, Randall ME (2005) Adjuvant radiotherapy in endometrial carcinoma. Oncologist 10: 623–631PubMedCrossRef
49.
Zurück zum Zitat Straughn JM, Huh WK, Kelly FJ et al. (2002) Conservative management of stage I endometrial carcinoma after surgical staging. Gynecol Oncol 84: 194–200PubMedCrossRef Straughn JM, Huh WK, Kelly FJ et al. (2002) Conservative management of stage I endometrial carcinoma after surgical staging. Gynecol Oncol 84: 194–200PubMedCrossRef
50.
Zurück zum Zitat Susini T, Massi G, Amunni G et al. (2005) Vaginal hysterectomy and abdominal hysterectomy for treatment of endometrial cancer in the elderly. Gynecol Oncol 96: 362–367PubMedCrossRef Susini T, Massi G, Amunni G et al. (2005) Vaginal hysterectomy and abdominal hysterectomy for treatment of endometrial cancer in the elderly. Gynecol Oncol 96: 362–367PubMedCrossRef
51.
Zurück zum Zitat Takeshima N, Hirai Y, Tanaka N et al. (1996) Pelvic lymph node metastasis in endometrial cancer with no myometrial invasion. Obstet Gynecol 88: 280–282PubMedCrossRef Takeshima N, Hirai Y, Tanaka N et al. (1996) Pelvic lymph node metastasis in endometrial cancer with no myometrial invasion. Obstet Gynecol 88: 280–282PubMedCrossRef
52.
Zurück zum Zitat Tozzi R, Malur S, Koehler C, Schneider A (2005) Analysis of morbidity in patients with endometrial cancer: is there a commitment to offer laparoscopy? Gynecol Oncol 97: 4–9PubMedCrossRef Tozzi R, Malur S, Koehler C, Schneider A (2005) Analysis of morbidity in patients with endometrial cancer: is there a commitment to offer laparoscopy? Gynecol Oncol 97: 4–9PubMedCrossRef
53.
Zurück zum Zitat Tozzi R, Malur S, Koehler C, Schneider A (2005) Laparoscopy versus laparotomy in endometrial cancer: first analysis of survival of a randomized prospective study. J Minim Invasive Gynecol 12: 130–136PubMedCrossRef Tozzi R, Malur S, Koehler C, Schneider A (2005) Laparoscopy versus laparotomy in endometrial cancer: first analysis of survival of a randomized prospective study. J Minim Invasive Gynecol 12: 130–136PubMedCrossRef
54.
Zurück zum Zitat Volpi E, Ferrero A, Jacomuzzi ME et al. (2006) Laparoscopic treatment of endometrial cancer: feasibility and results. Eur J Obstet Gynecol Reprod Biol 124: 232–236PubMedCrossRef Volpi E, Ferrero A, Jacomuzzi ME et al. (2006) Laparoscopic treatment of endometrial cancer: feasibility and results. Eur J Obstet Gynecol Reprod Biol 124: 232–236PubMedCrossRef
55.
Zurück zum Zitat Wang PH, Yen MS, Yuan CC et al. (1997) Port site metastasis after laparoscopic-assisted vaginal hysterectomy for endometrial cancer: possible mechanisms and prevention. Gynecol Oncol 66: 151–155PubMedCrossRef Wang PH, Yen MS, Yuan CC et al. (1997) Port site metastasis after laparoscopic-assisted vaginal hysterectomy for endometrial cancer: possible mechanisms and prevention. Gynecol Oncol 66: 151–155PubMedCrossRef
56.
Zurück zum Zitat Yokoyama Y, Maruyama H, Sato S, Saito Y (1997) Indispensability of pelvic and paraaortic lymphadenectomy in endometrial cancer. Gynecol Oncol 64: 411–417PubMedCrossRef Yokoyama Y, Maruyama H, Sato S, Saito Y (1997) Indispensability of pelvic and paraaortic lymphadenectomy in endometrial cancer. Gynecol Oncol 64: 411–417PubMedCrossRef
57.
Zurück zum Zitat Zapico A, Fuentes P, Grassa A et al. (2005) Laparoscopic-assisted vaginal hysterectomy versus abdominal hysterectomy in stages I and II endometrial cancer: operating data, follow-up and survival. Gynecol Oncol 98: 222–227PubMedCrossRef Zapico A, Fuentes P, Grassa A et al. (2005) Laparoscopic-assisted vaginal hysterectomy versus abdominal hysterectomy in stages I and II endometrial cancer: operating data, follow-up and survival. Gynecol Oncol 98: 222–227PubMedCrossRef
Metadaten
Titel
Die Therapie von Frauen mit Endometriumkarzinom
verfasst von
PD Dr. G. Hänsgen
D. Grund
A. Schneider
S. Marnitz
Prof. Dr. C. Köhler
Publikationsdatum
01.06.2008
Verlag
Springer-Verlag
Erschienen in
Die Onkologie / Ausgabe 6/2008
Print ISSN: 2731-7226
Elektronische ISSN: 2731-7234
DOI
https://doi.org/10.1007/s00761-008-1392-3

Weitere Artikel der Ausgabe 6/2008

Die Onkologie 6/2008 Zur Ausgabe

Einführung zum Thema

Keimzelltumoren des Mannes

Neu im Fachgebiet Onkologie

Muskeln trainieren gegen Nervenschäden durch Chemotherapie

17.07.2024 Nebenwirkungen der Krebstherapie Nachrichten

Chemotherapien können die Nerven schädigen und damit die Lebensqualität von Betroffenen zusätzlich einschränken. Wer aber auf die richtige Art trainiert, kann das absolute Risiko für Neuropathien um bis zu 40% senken.

Die beste Jahreszeit für eine Krebsimmuntherapie

16.07.2024 Onkologische Immuntherapie Nachrichten

Schon länger ist bekannt, dass die Aktivität des Immunsystems mit den Jahreszeiten variiert. Auch die Wirksamkeit von Checkpointhemmern scheint klinisch relevanten saisonalen Schwankungen zu unterliegen, wie eine Studie bei fortgeschrittenem nichtkleinzelligem Lungenkarzinom zeigt.

Partielle Nephrektomie: Videoanalysen zur Verbesserung der chirurgischen Qualität

16.07.2024 Nephrektomie Nachrichten

Je versierter Operateurinnen und Operateure sind, desto geringer ist das Risiko für Komplikationen. Eine kleine US-Studie spricht dafür, dass das auch bei Roboter-assistierten Nephrektomien gilt – und dass sich Op.-Videos für die Beurteilung eignen.        

S3-Leitlinie Endometriumkarzinom aktualisiert

15.07.2024 Endometriumkarzinom Nachrichten

Die angepasste Version der S3-Leitlinie Endometriumkarzinom enthält unter anderem Empfehlungen zu Risikofaktoren, wie der Hormonersatztherapie, sowie darüber, wann eine vaginale Brachytherapie und wann eine Perkutanbestrahlung angebracht ist.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.